Abstract
Background: Masses in head of pancreas may arise from Carcinoma head of pancreas or Chronic pancreatitis. There is a need for differentiating the type of pancreatic head masses with utmost priority, since it can convert a radical surgery to conventional procedure. Recent studies suggest that Platelet lymphocyte ratio (PLR) can be used as a marker for differentiating between these masses. We evaluated the role of PLR and other tumour markers with combinations in differentiating the masses in head of the pancreas. Methods: A total of Sixty patients with mass in the head of pancreas with size 2cm or greater were included in the study, with 30 patients in the Pancreatic ductal adenocarcinoma (PDA) group and 30 patients in the Chronic Pancreatitis group. Patients with evidence of acute pancreatitis, liver cirrhosis, cholangitis and obstructive jaundice, having Lewis antigen A/B blood types, with absent tissue /cytological diagnosis were excluded. Results: Haematological parameters like platelet count, neutrophil count, lymphocyte count were not statistically significanct between the two groups, whereas, Mean CA 19-9 levels, (PLR) Platelet lymphocyte ratio levels and (NLR) Neutrophil lymphocyte ratio in (PDA) Pancreatic ductal adenocarcinoma were higher than Chronic pancreatitis group. (P PLR+CA 19-9> CA 19-9> CA 19-9+NLR> NLR. Conclusion: We found that PLR is as good as tumour marker CA 19-9 both individually as well as with other tumour marker combinations in the diagnosis of pathology of pancreatic head masses. Cost effectiveness, availability, simplicity and better diagnostic accuracy made PLR better tumour marker in the current scenario.
Highlights
Masses in the Head of the pancreas always pose a diagnostic dilemma to differentiate the nature, as they may arise from Carcinoma head of pancreas or Chronic pancreatitis
When we analysed the differences in risk factors between these two groups, we found that smoking (40%) and obesity (39%) in Pancreatic ductal adenocarcinoma (PDA) group and alcoholism (91%) in chronic pancreatitis group were statistically significance. (Table-1)
60% of patients with PDA were above the age of 56 years, and 40% of patients were below 56 years
Summary
Masses in the Head of the pancreas always pose a diagnostic dilemma to differentiate the nature, as they may arise from Carcinoma head of pancreas or Chronic pancreatitis. We evaluated the role of PLR and other tumour markers with combinations in differentiating the masses in head of the pancreas. Methods: A total of Sixty patients with mass in the head of pancreas with size 2cm or greater were included in the study, with 30 patients in the Pancreatic ductal adenocarcinoma (PDA) group and 30 patients in the Chronic Pancreatitis group. Results: Haematological parameters like platelet count, neutrophil count, lymphocyte count were not statistically significanct between the two groups, whereas, Mean CA 19-9 levels, (PLR) Platelet lymphocyte ratio levels and (NLR) Neutrophil lymphocyte ratio in (PDA) Pancreatic ductal adenocarcinoma were higher than Chronic pancreatitis group. (P
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Surgical Update: International Journal of Surgery and Orthopedics
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
